Literature DB >> 27746320

Alpha-synuclein aggregates are excluded from calbindin-D28k-positive neurons in dementia with Lewy bodies and a unilateral rotenone mouse model.

Alexandre N Rcom-H'cheo-Gauthier1, Amelia Davis1, Adrian C B Meedeniya1, Dean L Pountney2.   

Abstract

α-Synuclein (α-syn) aggregates (Lewy bodies) in Dementia with Lewy Bodies (DLB) may be associated with disturbed calcium homeostasis and oxidative stress. We investigated the interplay between α-syn aggregation, expression of the calbindin-D28k (CB) neuronal calcium-buffering protein and oxidative stress, combining immunofluorescence double labelling and Western analysis, and examining DLB and normal human cases and a unilateral oxidative stress lesion model of α-syn disease (rotenone mouse). DLB cases showed a greater proportion of CB+ cells in affected brain regions compared to normal cases with Lewy bodies largely present in CB- neurons and virtually undetected in CB+ neurons. The unilateral rotenone-lesioned mouse model showed a greater proportion of CB+ cells and α-syn aggregates within the lesioned hemisphere than the control hemisphere, especially proximal to the lesion site, and α-syn inclusions occurred primarily in CB- cells and were almost completely absent in CB+ cells. Consistent with the immunofluorescence data, Western analysis showed the total CB level was 25% higher in lesioned compared to control hemisphere in aged animals that are more sensitive to lesion and 20% higher in aged compared to young mice in lesioned hemisphere, but not significantly different between young and aged in the control hemisphere. Taken together, the findings show α-syn aggregation is excluded from CB+ neurons, although the increased sensitivity of aged animals to lesion was not related to differential CB expression. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha-synuclein; Calbindin-D28k; Calcium; Dementia with Lewy Bodies; Neurodegeneration; Oxidative stress; Parkinson's disease

Mesh:

Substances:

Year:  2016        PMID: 27746320     DOI: 10.1016/j.mcn.2016.10.003

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  8 in total

1.  Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress.

Authors:  Jaime N Guzman; Ema Ilijic; Ben Yang; Javier Sanchez-Padilla; David Wokosin; Dan Galtieri; Jyothisri Kondapalli; Paul T Schumacker; D James Surmeier
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

Review 2.  'A picture is worth a thousand words': The use of microscopy for imaging neuroinflammation.

Authors:  Luciano Stürmer de Fraga; Isadora D'Ávila Tassinari; Jeferson Jantsch; Renata Padilha Guedes; Victorio Bambini-Junior
Journal:  Clin Exp Immunol       Date:  2021-10-10       Impact factor: 4.330

3.  Calcium Homeostasis in Parkinson's Disease: From Pathology to Treatment.

Authors:  Jingxian Zhang; Qingqing Shen; Yue Ma; Lin Liu; Wenting Jia; Leilei Chen; Junxia Xie
Journal:  Neurosci Bull       Date:  2022-06-21       Impact factor: 5.271

Review 4.  Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies.

Authors:  Alexandre N Rcom-H'cheo-Gauthier; Samantha L Osborne; Adrian C B Meedeniya; Dean L Pountney
Journal:  Front Neurosci       Date:  2016-12-20       Impact factor: 4.677

Review 5.  The role of Ca2+ signaling in Parkinson's disease.

Authors:  Sofia V Zaichick; Kaitlyn M McGrath; Gabriela Caraveo
Journal:  Dis Model Mech       Date:  2017-05-01       Impact factor: 5.758

Review 6.  Switching on Endogenous Metal Binding Proteins in Parkinson's Disease.

Authors:  Fleur A McLeary; Alexandre N Rcom-H'cheo-Gauthier; Michael Goulding; Rowan A W Radford; Yuho Okita; Peter Faller; Roger S Chung; Dean L Pountney
Journal:  Cells       Date:  2019-02-19       Impact factor: 6.600

Review 7.  Voltage-Gated Calcium Channels and α-Synuclein: Implications in Parkinson's Disease.

Authors:  Emmanouela Leandrou; Evangelia Emmanouilidou; Kostas Vekrellis
Journal:  Front Mol Neurosci       Date:  2019-10-09       Impact factor: 5.639

8.  Alleviating toxic α-Synuclein accumulation by membrane depolarization: evidence from an in vitro model of Parkinson's disease.

Authors:  Alysia Ross; Viktoria Xing; Ting Ting Wang; Samantha C Bureau; Giovana A Link; Teresa Fortin; Hui Zhang; Shawn Hayley; Hongyu Sun
Journal:  Mol Brain       Date:  2020-07-31       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.